203 related articles for article (PubMed ID: 26565758)
1. Understanding adherence to medications in type 2 diabetes care and clinical trials to overcome barriers: a narrative review.
Tiktin M; Celik S; Berard L
Curr Med Res Opin; 2016; 32(2):277-87. PubMed ID: 26565758
[TBL] [Abstract][Full Text] [Related]
2. Health care costs and medication adherence associated with initiation of insulin pen therapy in Medicaid-enrolled patients with type 2 diabetes: a retrospective database analysis.
Pawaskar MD; Camacho FT; Anderson RT; Cobden D; Joshi AV; Balkrishnan R
Clin Ther; 2007 Jun; 29(6 Pt 1):1294-305. PubMed ID: 18036391
[TBL] [Abstract][Full Text] [Related]
3. The effectiveness of therapeutic patient education on adherence to oral anti-cancer medicines in adult cancer patients in ambulatory care settings: a systematic review.
Arthurs G; Simpson J; Brown A; Kyaw O; Shyrier S; Concert CM
JBI Database System Rev Implement Rep; 2015 Jun; 13(5):244-92. PubMed ID: 26455611
[TBL] [Abstract][Full Text] [Related]
4. Health care costs and medication adherence associated with initiation of insulin pen therapy in medicaid-enrolled patients with type 2 diabetes: a retrospective database analysis.
Pawaskar MD; Camacho FT; Anderson RT; Cobden D; Joshi AV; Balkrishnan R
Clin Ther; 2007; 29 Spec No():1294-305. PubMed ID: 18046929
[TBL] [Abstract][Full Text] [Related]
5. Adherence to premixed insulin in a prefilled pen compared with a vial/syringe in people with diabetes in Singapore.
Cheen HH; Lim SH; Huang MC; Bee YM; Wee HL
Clin Ther; 2014 Jul; 36(7):1043-53. PubMed ID: 24913030
[TBL] [Abstract][Full Text] [Related]
6. Medication adherence and the associated health-economic impact among patients with type 2 diabetes mellitus converting to insulin pen therapy: an analysis of third-party managed care claims data.
Lee WC; Balu S; Cobden D; Joshi AV; Pashos CL
Clin Ther; 2006 Oct; 28(10):1712-25; discussion 1710-1. PubMed ID: 17157128
[TBL] [Abstract][Full Text] [Related]
7. A systematic review of interventions addressing adherence to anti-diabetic medications in patients with type 2 diabetes--impact on adherence.
Sapkota S; Brien JA; Greenfield J; Aslani P
PLoS One; 2015; 10(2):e0118296. PubMed ID: 25710465
[TBL] [Abstract][Full Text] [Related]
8. Medication adherence among cardiac patients in Khartoum State, Sudan: a cross-sectional study.
Awad A; Osman N; Altayib S
Cardiovasc J Afr; 2017 Nov/Dec 23; 28(6):350-355. PubMed ID: 28345729
[TBL] [Abstract][Full Text] [Related]
9. Determinants of adherence to diabetes medications: findings from a large pharmacy claims database.
Kirkman MS; Rowan-Martin MT; Levin R; Fonseca VA; Schmittdiel JA; Herman WH; Aubert RE
Diabetes Care; 2015 Apr; 38(4):604-9. PubMed ID: 25573883
[TBL] [Abstract][Full Text] [Related]
10. Patient adherence to medication requirements for therapy of type 2 diabetes.
Bailey CJ; Kodack M
Int J Clin Pract; 2011 Mar; 65(3):314-22. PubMed ID: 21314869
[TBL] [Abstract][Full Text] [Related]
11. Adherence to and persistence with antidiabetic medications and associations with clinical and economic outcomes in people with type 2 diabetes mellitus: A systematic literature review.
Evans M; Engberg S; Faurby M; Fernandes JDDR; Hudson P; Polonsky W
Diabetes Obes Metab; 2022 Mar; 24(3):377-390. PubMed ID: 34779107
[TBL] [Abstract][Full Text] [Related]
12. Systematic review of adherence rates by medication class in type 2 diabetes: a study protocol.
McGovern A; Tippu Z; Hinton W; Munro N; Whyte M; de Lusignan S
BMJ Open; 2016 Feb; 6(2):e010469. PubMed ID: 26928029
[TBL] [Abstract][Full Text] [Related]
13. Oral antidiabetic drug use and associated health outcomes in cancer patients.
Tan X; Feng X; Chang J; Higa G; Wang L; Leslie D
J Clin Pharm Ther; 2016 Oct; 41(5):524-31. PubMed ID: 27453485
[TBL] [Abstract][Full Text] [Related]
14. Does pen help? A real-world outcomes study of switching from vial to disposable pen among insulin glargine-treated patients with type 2 diabetes mellitus.
Xie L; Zhou S; Wei W; Gill J; Pan C; Baser O
Diabetes Technol Ther; 2013 Mar; 15(3):230-6. PubMed ID: 23336845
[TBL] [Abstract][Full Text] [Related]
15. Treatment adherence in newly diagnosed type 2 diabetes: patient characteristics and long-term impact of adherence on inpatient care utilization.
Sun P; Lian J
Postgrad Med; 2016 May; 128(4):338-45. PubMed ID: 26849064
[TBL] [Abstract][Full Text] [Related]
16. Refill adherence and polypharmacy among patients with type 2 diabetes in general practice.
van Bruggen R; Gorter K; Stolk RP; Zuithoff P; Klungel OH; Rutten GE
Pharmacoepidemiol Drug Saf; 2009 Nov; 18(11):983-91. PubMed ID: 19623570
[TBL] [Abstract][Full Text] [Related]
17. Impact of type 2 diabetes medication cost sharing on patient outcomes and health plan costs.
Thornton Snider J; Seabury S; Lopez J; McKenzie S; Goldman DP
Am J Manag Care; 2016 Jun; 22(6):433-40. PubMed ID: 27355811
[TBL] [Abstract][Full Text] [Related]
18. Impact of initiating insulin glargine disposable pen versus vial/syringe on real-world glycemic outcomes and persistence among patients with type 2 diabetes mellitus in a large managed care plan: a claims database analysis.
Xie L; Zhou S; Pinsky BW; Buysman EK; Baser O
Diabetes Technol Ther; 2014 Sep; 16(9):567-75. PubMed ID: 24735083
[TBL] [Abstract][Full Text] [Related]
19. Characteristics Relating to Adherence and Persistence to Basal Insulin Regimens Among Elderly Insulin-Naïve Patients with Type 2 Diabetes: Pre-Filled Pens versus Vials/Syringes.
Slabaugh SL; Bouchard JR; Li Y; Baltz JC; Meah YA; Moretz DC
Adv Ther; 2015 Dec; 32(12):1206-21. PubMed ID: 26563324
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
